ArticleOPEN ACCESS

BCL6 inhibition: A chronic GVHD twofer

Blood
DOI: 10.1182/blood-2018-11-879692
4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Paz and colleagues demonstrate that the small molecule 79-6 is able to treat and even reverse lung injury attributable to experimental chronic graft-versus-host disease (cGVHD) by targeting B-cell lymphoma 6 (BCL6), a transcriptional regulator of T follicular helper (Tfh) cells and germinal center B cells.1

Cite

CITATION STYLE

APA

Vinci, P., & Hanash, A. M. (2019, January 3). BCL6 inhibition: A chronic GVHD twofer. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-11-879692

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free